Brain extracellular levels of the putative antipsychotic CI-1007 and its effects on striatal and nucleus accumbens dopamine overflow in the awake rat

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 10, 1998, Pages 1147-1153

  Iyer, Raj N ^a,b   Davis, M Duff ^a   Juneau, Paul L ^a   Giordani, Anne B ^a  

^a PFIZER INC   (United States)

^b Dey Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 4 PHENYL 1 [(3 PHENYL 3 CYCLOHEXEN 1 YL)METHYL]PYRIDINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BLOOD BRAIN BARRIER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DRUG BRAIN LEVEL; ELECTROCHEMICAL DETECTION; EXTRAPYRAMIDAL SYMPTOM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRACEREBRAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MICRODIALYSIS; MOTOR PERFORMANCE; NEUROCHEMISTRY; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; RAT; SCHIZOPHRENIA; TANDEM MASS SPECTROMETRY;

EID: 0031736889     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb03326.x     Document Type: Article

References (25)

1. Aghajanian, G. K., Bunney, B. S. (1977) Dopamine autoreceptors: pharmacological characterization of microiontophoretic single cell recording studies. Naunyn Schmiedebergs Arch. Pharmacol. 297: 1-17
2. Baldwin, S., Nugent, K., Wheeler, K., Mylchreest, I. (1996) Low pH solvent alternatives to TFA solvents and their effect on HPLC ESI/MS of peptides. Proc. 44th ASMS Conference on Mass Spectrometry and Allied Topics, May 12-16, Portland, Oregon, p. 207
3. Carlsson, A. (1983) Dopamine receptor agonists: intrinsic activity vs state of receptor. J. Neural Transm. 57: 309-315
4. Carlsson, A. (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1: 179-186
5. Clark, D., Hjorth, S., Carlsson, A. (1985a) Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. J. Neural Transm. 62: 1-52
6. Clark, D., Hjorth, S., Carlsson, A. (1985b) Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. J. Neural Transm. 62: 171-207
7. Feng, R. M., Strenkoski, C., Parker, T., Wright, D. S. (1993) Oral availability of PD 1413188 in rats and monkeys. Pharm. Res. 10: S-320
8. Feng, R. M., Bezek, S., Gandhi, A., Strenkoski, C., Woolf, T., Wright, D. S. (1994) Pharmacokinetics and metabolism of CI-1007 and analogues in rats and isolated rat hepatocytes. Pharm. Res. 10: S-347
9. Fenn, J. B, Mann, M., Meng, C. K., Wong, S. F., Whitehouse, C. M. (1989) Electrospray ionization for mass spectrometry of large biomolecules. Science 246: 64-71
10. French, J. B., Thomson, B. A., Davidson, W. R., Reid, N. M., Buckley, J. A. (1985) Atmospheric pressure chemical ionization mass spectrometry. In: Karasek, F. W., Hutzinger, O., Safe , S. (eds) Mass Spectrometry in the Environmental Sciences. Plenum Press, New York
11. Meller, E., Bohmaker, K., Namba, Y., Friedhoff, A. J., Goldstein, M. (1987) Relationship between receptor occupancy and response at striatal dopamine autoreceptors. Mol. Pharmacol. 31: 592-598
12. Meltzer, L. T., Christoffersen, C. L., Corbin, A. E., Ninteman, F. W., Serpa, K. A., Wiley, J. N., Wise, L. D., Heffner, T. G. (1995) CI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioural effects. J. Pharmacol. Exp. Ther. 274: 912-920
13. Meng, C. K., Mann, M., Fenn, J. B. (1988) Of protons or proteins. Z. Phys. D 10: 361-368
14. Niessen, W. M. A., van der Greef, J. (1992) Liquid Chromatography-Mass Spectrometry, Chromatographic Science Series, Vol. 58. Marcel Dekker, New York, p. 407-409
15. Paxinos, G., Watson, C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York
16. Pugsley, T. A., Davis, M. D., Akunne, H. C., Cooke, L. W., Whetzel, S. W., Mackenzie, R. G., Shih, Y.-H., Van Leeuwen, D. H., Demattos, S. B., Georgic, L. M., Caprathe, B. W., Wright, J. C., Jaen, J. C., Wise, L. D., Heffner, T. G. (1995) CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects. J. Pharmacol. Exp. Ther. 274: 898-911
17. Robinson, T. E., Justice, J. B. (1991) Microdialysis in the Neurosciences. Elsevier, New York
18. Roth, R. H. (1984) CNS dopamine autoreceptors: distribution, pharmacology and function. Ann. NY Acad. Sci. 430: 27-53
19. Seeman, P. (1980) Brain dopamine receptors. Pharmacol. Rev. 32: 229-313
20. Seeman, P. (1987) Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1: 133-152
21. Shahin, M. M. (1967) Mass spectrometric studies of corona discharges for the study of ion-molecule reactions. J. Chem. Phys. 47: 4392-4398
22. Vinick, F. J., Heym, J. H. (1987) Antipsychotic agents. Annu. Rev. Med. Chem. 22: 1-10
23. Weinberger, D. R., Berman, K. F., Daniel, D. G. (1992) Mesoprefrontal cortical dopaminergic activity and prefrontal hypofunction in schizophrenia. Clin. Neuropharmacol. 15 (Suppl. 1): 568A-569A
24. White, F. J., Wang, R. Y. (1984) Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies. J. Pharmacol. Exp. Ther. 231: 275-280
25. Wright, J. L., Caprathe, B. W., Downing, D. M., Glase, S. A., Heffner, T. G., Jaen, J. C., Johnson, S. J., Kesten, S. R., Mackenzie, R. G., Meltzer, L. T., Pugsley, T. A., Smith, S. J., Wise, L. D., Wustrow, D. J. (1994) The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)-alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agents. J. Med. Chem. 37: 3523-3533